Ratings by Chardan (David Gataulin)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/15/2023 | Frequency Therapeutics | FREQ | Downgrade | Neutral (Buy) |
0.75 (0.30) |
-60% | Details | |
| 12/8/2022 | Frequency Therapeutics | FREQ | New Coverage | Buy (N/A) |
2.01 (0.30) |
-85.07% | Details |
